Shifting landscape of COVID-19 pivotal and registrational trials
Entry into the market may be difficult for Covid-19 vaccines awaiting approval as global vaccination rollout continues.
Manufacturing
N-SIDE on streamlining production for clinical trials
N-SIDE’s Sébastien Coppe discusses the firm’s new Production App and how it helps optimise manufacturing...
Vaxxinity CEO Mei Mei Hu on vaccine research and democratising health
Vaxxinity CEO Mei Mei Hu discusses her newly-formed company, its vaccine programmes and her mission...
GSK to expand clinical trial manufacturing capacity at CGT Catapult site in UK
GlaxoSmithKline (GSK) will expand its presence at the UK Cell and Gene Therapy (CGT) Catapult’s...
Brexit deal secures UK access to EU’s €95.5B research and innovation programme, Horizon Europe
Through the Brexit deal struck between the UK and EU on 24 December, the UK...
How medical-grade silicone can transform transdermal drug delivery
Delivering therapeutic drugs by applying substances to the skin is a practise that dates back thousands of years, but is has only been since the 1970s that we have better…
Top ten pharma companies in 2020
The global pharmaceutical industry is expected to witness positive growth as the top pharma companies are at forefront of the fight against COVID-19.
A case for streamlined RFIs in the pharmaceutical industry
External suppliers are used extensively throughout the pharma industry, but how can new client-supplier relationships be managed and defined most effectively? Pfizer's senior director for drug product supply external strategy Francis Dumont makes the case...
Anti-GM-CSF antibodies expected to show better effect in Covid-19 than cytokine-specific targets
by Ayisha Sharma in London and Manasi Vaidya in New York. Anti-granulocyte-macrophage colony-stimulating factor (GM-CSF) antibody treatments in development for Covid-19, such as by Roivant Sciences, Humanigen) and I-Mab Biopharma,…
Largest Covid-19 trials studying Umifenovir or traditional Chinese medicine
In light of the coronavirus (Covid-19) outbreak, GlobalData has analysed the five largest Covid-19 clinical trials in terms of participant size. GDCT0379047 (ChiCTR2000029573) and GDCT0379500 (ChiCTR2000029602) are the two largest…
August’s top news stories
Biopharmaceutical firm Retrophin reported that the Phase III clinical trial of fosmetpantotenate failed to meet endpoints in pantothenate kinase-associated neurodegeneration (PKAN) patients; and MyoKardia has commenced dosing of patients in a Phase I trial of...
